Latest News and Press Releases
Want to stay updated on the latest news?
-
NodThera Ltd (“NodThera” or the “Company”) NodThera announces positive first-in-human data for two brain penetrant NLRP3 inflammasome inhibitors Oral, small molecule, clinical candidates NT-0249...
-
NodThera Ltd(“NodThera” or the “Company”) NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening...
-
NodThera Ltd(“NodThera” or the “Company”) NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening...
-
NodThera(“NodThera” or the “Company”) NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer Dr Keeney joins NodThera with over 20 years of...
-
NodThera(“NodThera” or the “Company”) NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer Dr Keeney joins NodThera with over 20 years of...
-
NodThera(“NodThera” or the “Company”) NodThera secures £28 million ($40 million) Series A Financing NodThera discovers and develops next generation NLRP3 inflammasome inhibitors for the treatment...